Gonadotropins regulate reproductive functions by binding to G protein-coupled receptors (FSHR and LHCGR) expressed in the gonads. They activate multiple, cell-specific signalling pathways, consisting of ligand-dependent intracellular events. Signalling cascades may be modulated by synthetic compounds which bind allosteric sites of FSHR and LHCGR or by membrane receptor interactions. Despite the hormone binding to the orthosteric site, allosteric ligands, and receptor heteromerizations may reshape intracellular signalling pattern. These molecules act as positive, negative, or neutral allosteric modulators, as well as non-competitive or inverse agonist ligands, providing a set of new compounds of a different nature and with unique pharmacological characteristics. Gonadotropin receptor allosteric modulation is gathering increasing interest from the scientific community and may be potentially exploited for clinical purposes. This review summarizes the current knowledge on gonadotropin receptor allosteric modulation and their potential, clinical use.

Allosteric modulation of gonadotropin receptors / Lazzaretti, Clara; Simoni, Manuela; Casarini, Livio; Paradiso, Elia. - In: FRONTIERS IN ENDOCRINOLOGY. - ISSN 1664-2392. - 14:(2023), pp. N/A-N/A. [10.3389/fendo.2023.1179079]

Allosteric modulation of gonadotropin receptors

Lazzaretti, Clara;Simoni, Manuela;Casarini, Livio;Paradiso, Elia
2023

Abstract

Gonadotropins regulate reproductive functions by binding to G protein-coupled receptors (FSHR and LHCGR) expressed in the gonads. They activate multiple, cell-specific signalling pathways, consisting of ligand-dependent intracellular events. Signalling cascades may be modulated by synthetic compounds which bind allosteric sites of FSHR and LHCGR or by membrane receptor interactions. Despite the hormone binding to the orthosteric site, allosteric ligands, and receptor heteromerizations may reshape intracellular signalling pattern. These molecules act as positive, negative, or neutral allosteric modulators, as well as non-competitive or inverse agonist ligands, providing a set of new compounds of a different nature and with unique pharmacological characteristics. Gonadotropin receptor allosteric modulation is gathering increasing interest from the scientific community and may be potentially exploited for clinical purposes. This review summarizes the current knowledge on gonadotropin receptor allosteric modulation and their potential, clinical use.
2023
14
N/A
N/A
Allosteric modulation of gonadotropin receptors / Lazzaretti, Clara; Simoni, Manuela; Casarini, Livio; Paradiso, Elia. - In: FRONTIERS IN ENDOCRINOLOGY. - ISSN 1664-2392. - 14:(2023), pp. N/A-N/A. [10.3389/fendo.2023.1179079]
Lazzaretti, Clara; Simoni, Manuela; Casarini, Livio; Paradiso, Elia
File in questo prodotto:
File Dimensione Formato  
fendo-14-1179079.pdf

Open access

Tipologia: Versione pubblicata dall'editore
Dimensione 867.29 kB
Formato Adobe PDF
867.29 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1314067
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 3
social impact